Silverlake Wealth Management LLC Has $301,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Silverlake Wealth Management LLC lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 6.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 902 shares of the company’s stock after selling 66 shares during the quarter. Silverlake Wealth Management LLC’s holdings in HCA Healthcare were worth $301,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Parkside Financial Bank & Trust raised its stake in shares of HCA Healthcare by 8.2% in the fourth quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock worth $125,000 after acquiring an additional 35 shares during the last quarter. FinTrust Capital Advisors LLC lifted its stake in shares of HCA Healthcare by 26.7% during the fourth quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock valued at $45,000 after acquiring an additional 35 shares during the period. Ballentine Partners LLC raised its holdings in HCA Healthcare by 1.0% during the 1st quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock worth $1,294,000 after purchasing an additional 38 shares during the last quarter. Wedmont Private Capital raised its stake in shares of HCA Healthcare by 1.6% during the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock worth $711,000 after buying an additional 39 shares during the last quarter. Finally, Valley Wealth Managers Inc. raised its position in shares of HCA Healthcare by 4.1% during the 4th quarter. Valley Wealth Managers Inc. now owns 981 shares of the company’s stock valued at $266,000 after acquiring an additional 39 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on HCA. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday. Oppenheimer raised their price target on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research report on Monday, April 29th. Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 28th. Barclays increased their target price on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. Finally, Robert W. Baird assumed coverage on HCA Healthcare in a report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $326.53.

Insider Activity

In related news, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction dated Wednesday, May 15th. The shares were sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the sale, the senior vice president now owns 19,612 shares of the company’s stock, valued at $6,397,042.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Kathryn A. Torres sold 1,863 shares of the business’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the completion of the transaction, the senior vice president now owns 19,612 shares of the company’s stock, valued at approximately $6,397,042.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael S. Cuffe sold 6,311 shares of the stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the completion of the transaction, the executive vice president now directly owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The disclosure for this sale can be found here. In the last three months, insiders sold 12,397 shares of company stock worth $3,921,929. 1.70% of the stock is currently owned by company insiders.

HCA Healthcare Price Performance

NYSE:HCA opened at $319.70 on Wednesday. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $344.20. The company has a market cap of $83.73 billion, a P/E ratio of 15.94, a P/E/G ratio of 1.49 and a beta of 1.68. The firm’s fifty day moving average price is $326.06 and its two-hundred day moving average price is $317.80. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. During the same period in the previous year, the company posted $4.93 EPS. The firm’s quarterly revenue was up 11.2% on a year-over-year basis. Equities analysts expect that HCA Healthcare, Inc. will post 20.92 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date was Friday, June 14th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.